Sirnaomics Sirnaomics Files to Begin Trial of Scar-healing Drug in China as it Seeks Funding in US Premium The company is also pushing ahead with a microRNA-replacement therapy that is designed to improve patient response to colon cancer treatment. Sirnaomics Presents Preclinical HPV Data Premium Sirnaomics this week released preclinical data showing that two siRNAs against different strains of human papillomavirus could halt growth of papillomas in an animal model of HPV infection. Sirnaomics Nears Phase I Study of Wound-Healing Drug as It Eyes the microRNA Field Premium Sirnaomics could begin phase I testing of its siRNA-based wound-healing drug candidate STP-705 as soon as next year and expects to run the trial in China, a company official told Gene Silencing News this week. Sirnaomics Inks Ocular Disease Drug Deal with Chinese Drugmaker Premium The partnership will specifically include STP601, Sirnaomics' preclinical treatment for ocular neovascularization diseases, in the Greater China and Southeast Asian markets. Sirnaomics Partners with Chinese Pharma on Wound-Healing Drug Premium The drug, STP705, uses a polymeric nanoparticle to enhance topical delivery of siRNAs targeting the TGF-beta 1 and Cox-2 genes to open wounds, Sirnaomics said. Jul 8, 2010 NIH Awards Three Grants Supporting RNAi, microRNA Rx Development Premium Jun 24, 2010 Sirnaomics Aims to Move Wound-Healing Drug into Phase I Next Year Premium Jun 17, 2010 Choosing Skin and Eye Disorders, RXi Will Face Well-Worn R&D Paths Premium Jan 14, 2010 Sirnaomics Licenses Polypeptide Nanoparticle Delivery Technology from University of Maryland Medical School Premium Jul 23, 2009 Sirnaomics Receives NCI Grant to Develop siRNA-Based Lung Cancer Rx Premium Feb 24, 2009 Sirnaomics Considers Hong Kong for Ocular Rx Trial Premium Feb 5, 2009 Sirnaomics Considers Hong Kong for Ocular Disease Rx Trial, Advances Wound-Healing Program Premium Breaking News Ceres Nanosciences Wins $1.4M in NIH RADx Funding for Additional Wastewater Epidemiology Centers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer GenomeWeb Top 40 up 8 Percent in November, Outpacing Broader Market Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay ERS Genomics Licenses CRISPR-Cas9 IP to Cosmo Bio The Scan New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability. Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances. New mRNA Vaccines Offer Hope for Fighting Malaria A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines. Unique Germline Variants Found Among Black Prostate Cancer Patients Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.